Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ciavarella

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
British Journal of Haematology|May 1, 1981
Factor VII deficiency: immunological characterization of genetic variants and detection of carriersG Mariani, M G Mazzucconi, J Hermans, et al.
American Journal of Hematology|December 1, 1986
Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patientsA R Zanetti, P M Mannucci, E Tanzi, et al.
Lancet (London, England)|August 17, 1996
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant TherapyG Palareti, N Leali, S Coccheri, et al.
Giornale Italiano Di Cardiologia|March 1, 1997
[Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)]G Palareti, N Leali, S Coccheri, et al.
Thrombosis and Haemostasis|January 10, 1998
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy)G Palareti, C Manotti, A DAngelo, et al.
Cell|April 18, 1998
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIIIW C Nichols, U Seligsohn, A Zivelin, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international surveyC R Hay, J N Lozier, C A Lee, et al.
Thrombosis Research|August 1, 1980
Multicenter evaluation of a new chromogenic factor X assay in plasma of patients on oral anticoagulantsN Ciavarella, S Coccheri, G F Gensini, et al.
Blood|March 26, 1999
ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency familiesW C Nichols, V H Terry, M A Wheatley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2010
Mortality and causes of death in Italian persons with haemophilia, 1990-2007A Tagliaferri, G F Rivolta, A Iorio, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
British Journal of Haematology|May 1, 1981
Factor VII deficiency: immunological characterization of genetic variants and detection of carriersG Mariani, M G Mazzucconi, J Hermans, et al.
American Journal of Hematology|December 1, 1986
Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patientsA R Zanetti, P M Mannucci, E Tanzi, et al.
Lancet (London, England)|August 17, 1996
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant TherapyG Palareti, N Leali, S Coccheri, et al.
Giornale Italiano Di Cardiologia|March 1, 1997
[Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)]G Palareti, N Leali, S Coccheri, et al.
Thrombosis and Haemostasis|January 10, 1998
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy)G Palareti, C Manotti, A DAngelo, et al.
Cell|April 18, 1998
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIIIW C Nichols, U Seligsohn, A Zivelin, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international surveyC R Hay, J N Lozier, C A Lee, et al.
Thrombosis Research|August 1, 1980
Multicenter evaluation of a new chromogenic factor X assay in plasma of patients on oral anticoagulantsN Ciavarella, S Coccheri, G F Gensini, et al.
Blood|March 26, 1999
ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency familiesW C Nichols, V H Terry, M A Wheatley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2010
Mortality and causes of death in Italian persons with haemophilia, 1990-2007A Tagliaferri, G F Rivolta, A Iorio, et al.
Pageof 6